These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20920444)

  • 1. Correct use of a new reusable insulin injection pen by patients with diabetes: a design validation study.
    Schwartz S
    J Diabetes Sci Technol; 2010 Sep; 4(5):1229-35. PubMed ID: 20920444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new reusable insulin pen (ClikSTAR) in Canadian patients with type 1 and type 2 diabetes mellitus receiving insulin glargine.
    Gottesman I; Perron P; Berard L; Stewart J; Basso N; Mettimano K; Elliott T
    Diabetes Technol Ther; 2012 Oct; 14(10):926-35. PubMed ID: 22775367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis: including visually impaired participants in validation design studies of diabetes technology.
    Uslan M; Blubaugh M
    J Diabetes Sci Technol; 2010 Sep; 4(5):1236-7. PubMed ID: 20920445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of a new disposable insulin pen and injection habits of diabetes patients in everyday clinical practice].
    Böhler S; Landgraf W; Schreiber SA
    MMW Fortschr Med; 2010 Jan; 151 Suppl 4():179-87. PubMed ID: 21595146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the SoloSTAR insulin pen.
    Schwartz S; Vlajnic A
    Diabetes Technol Ther; 2008 Oct; 10(5):351-7. PubMed ID: 18715210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes.
    Hancu N; Czupryniak L; Genestin E; Sourij H
    J Diabetes Sci Technol; 2011 Sep; 5(5):1224-34. PubMed ID: 22027323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.
    Hermanns N; Kulzer B; Haak T
    Diabetes Technol Ther; 2008 Aug; 10(4):322-7. PubMed ID: 18715206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pen needle preference in a population of Canadians with diabetes: results from a recent patient survey.
    Berard L; Cameron B; Woo V
    Can J Diabetes; 2015 Jun; 39(3):206-9. PubMed ID: 25732758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A; Spollett G
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia.
    Carter J; Beilin J; Morton A; De Luise M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1425-38. PubMed ID: 20144398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionality and acceptability of a new electronic insulin injection pen with a memory feature.
    Venekamp WJ; Kerr L; Dowsett SA; Johnson PA; Wimberley D; McKenzie C; Malone J; Milicevic Z
    Curr Med Res Opin; 2006 Feb; 22(2):315-25. PubMed ID: 16466603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection force of reusable insulin pens: Novopen 4, Lilly Luxura, Berlipen, and ClikSTAR.
    Friedrichs A; Korger V; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1185-90. PubMed ID: 22027315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes.
    Pohlmeier H; Berard L; Brulle-Wohlhueter C; Wu J; Dahmen R; Nowotny I; Klonoff D
    J Diabetes Sci Technol; 2017 Mar; 11(2):263-269. PubMed ID: 27664062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a new reusable insulin pen.
    Penfornis A
    Diabetes Technol Ther; 2011 Mar; 13(3):373-9. PubMed ID: 21291331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studies.
    Friedrichs A; Basso N; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1179-84. PubMed ID: 22027314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing accuracy of two insulin pre-filled pens.
    Asakura T; Seino H; Kageyama M; Yohkoh N
    Curr Med Res Opin; 2008 May; 24(5):1429-34. PubMed ID: 18400146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of initiating rapid-acting insulin analog using vial/syringe, prefilled pen, and reusable pen devices in patients with type 2 diabetes.
    Lee LJ; Anderson J; Foster SA; Corrigan SM; Smith DM; Curkendall S
    J Diabetes Sci Technol; 2010 May; 4(3):547-57. PubMed ID: 20513319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.
    Xie L; Zhou S; Wei W; Gill J; Pan C; Baser O
    Diabetes Technol Ther; 2013 Mar; 15(3):230-6. PubMed ID: 23336845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.